SAMANTHA KAPUSCINSKI: Open Payments
NPI 1821459066 · BEMUS POINT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$61 in 3 payments from 3 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $61
Food & beverage: $61
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $16 |
Products named: TRELEGY ELLIPTA, GARDASIL 9, Ozempic.
Industry payments across NY — which companies pay providers there.
